Evidence map›Paper›PMID 36810474›Full record

ReviewNeurology international2023

Monocyte to HDL and Neutrophil to HDL Ratios as Potential Ischemic Stroke Prognostic Biomarkers.

Aimilios Gkantzios, Dimitrios Tsiptsios, Vaia Karapepera, Stella Karatzetzou, Stratis Kiamelidis, Pinelopi Vlotinou, Erasmia Giannakou, Evangeli Karampina, Katerina Paschalidou, Nikolaos Kourkoutsakis and 3 more

Abstract readReview
In one paragraph

Review in Neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Investigation of Peripheral Inflammatory Biomarkers in Trichotillomania.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2026
    Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Aimilios GkantziosNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-0890-4069
Dimitrios TsiptsiosNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-1601-8788
Vaia KarapeperaNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Stella KaratzetzouNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Stratis KiamelidisNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Pinelopi VlotinouNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0002-8828-9093
Erasmia GiannakouNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Evangeli KarampinaDepartment of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece.
Katerina PaschalidouDepartment of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece.
Nikolaos KourkoutsakisRadiology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Nikolaos PapanasSecond Department of Internal Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece.
Nikolaos AggelousisDepartment of Physical Education and Sport Science, Democritus University of Thrace, 69100 Komotini, Greece.ORCID 0000-0001-5108-7335
Konstantinos VadikoliasNeurology Department, Democritus University of Thrace, 68100 Alexandroupolis, Greece.ORCID 0000-0003-0484-369X

Funding

"Competitiveness, Entrepreneurship and Innovation" Greece and the European Union (the European Regional Development Fund). NSRFm2014-2EYD-EPANEK MIS 5047286
6 · The paper itself

Abstract

Ischemic stroke (IS) exhibits significant heterogeneity in terms of etiology and pathophysiology. Several recent studies highlight the significance of inflammation in the onset and progression of IS. White blood cell subtypes, such as neutrophils and monocytes, participate in the inflammatory response in various ways. On the other hand, high-density lipoproteins (HDL) exhibit substantial anti-inflammatory and antioxidant actions. Consequently, novel inflammatory blood biomarkers have emerged, such as neutrophil to HDL ratio (NHR) and monocyte to HDL ratio (MHR). Literature research of two databases (MEDLINE and Scopus) was conducted to identify all relevant studies published between 1 January 2012 and 30 November 2022 dealing with NHR and MHR as biomarkers for IS prognosis. Only full-text articles published in the English language were included. Thirteen articles have been traced and are included in the present review. Our findings highlight the utility of NHR and MHR as novel stroke prognostic biomarkers, the widespread application, and the calculation of which, along with their inexpensive cost, make their clinical application extremely promising.

Indexed as

blood biomarkersMHRmonocyte to HDL-rationeutrophil to HDL-ratioNHRstroke outcomestroke prognosis

Identifiers

PMID36810474
PMCPMC9944118

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.